Bacterial antimicrobial resistance (AMR) contributed to 4.95 million deaths worldwide in 2019, making it one of the top global public health and development threats today according to the World Health Organisation.
At the ground-breaking Antimicrobial Stewardship Center of Excellence Symposium held in Kula Lumpur on 22 November, IHH Malaysia and our Premier Integrated Labs joined forces with bioMérieux, to drive industry collaboration in tackling AMR.
The symposium highlighted the importance of diagnostics in AMR control, the link between AMR and judicious use of antibiotics, and initiatives in the public and private healthcare sector for controlling AMR.
Jean-François Naa, CEO of IHH Healthcare Malaysia, expressed his commitment, stating, "At IHH Healthcare Malaysia, combating AMR is ingrained in our global sustainability goals. Our active AMS committee strategically spearheads initiatives. In this battle, knowledge is our strongest ally. The exchange of insights between global experts, local healthcare leaders, and private providers is crucial as we navigate uncharted waters. Moving forward, strategic collaboration is paramount to combat resistance instead of working in silos."
Related Stories
IHH Healthcare Advocates Long-term Sustainability Thinking at Future Economy Conference
At the recent Future Economy Conference 2026, IHH's Group Chief Sustainability Officer Yasemin Tecmen Stubbe shared why sustainability remains critical to business resilience and long-term value creation, particularly amid growing geopolitical uncertainty, climate risks and supply chain disruptions.
IHH Singapore Launches Great at Work Fest 2026
IHH Singapore officially launched Great at Work Fest 2026 (GAW Fest) on 11 May at the Centre for Healthcare Innovation, bringing together employees and leaders to celebrate workplace culture, service excellence, and employee wellbeing across its Singapore operations.
IHH Healthcare Aligns Teams in Malaysia and Singapore on Future-ready Healthcare Priorities
IHH Healthcare recently brought together employees across Malaysia’s Southern Region and Singapore for its Country Town Halls, reinforcing the Group’s focus on strengthening current healthcare capabilities while preparing for the evolving needs of the future.
Gleneagles JPMC performs first VARIPULSE procedure in Borneo
Cardiovascular Laboratory at Gleneagles JPMC continues to evolve, marked by new milestones in advanced heart rhythm procedures.
Stronger Together as One IHH, North Asia
Leaders, doctors, nurses and staff from Gleneagles Hospital Hong Kong and Parkway Shanghai, under IHH North Asia, recently participated in an offsite team-building experience designed to strengthen collaboration, connection and shared thinking across markets and functions.
Shaping the Future of Oncology at Fortis Cancer Summit 2026
Held on 1–3 May 2026 in New Delhi, the Fortis Cancer Summit 2026 brought together healthcare leaders, oncology experts and clinicians from around the world to exchange insights, strengthen partnerships and shape the future of cancer care.
